排序方式: 共有1条查询结果,搜索用时 0 毫秒
1
1.
Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma 总被引:6,自引:0,他引:6
MARIA-CHRISTINA KYRTSONIS GEORGES DEDOUSSIS CONSTANTIN ZERVAS VASSILIS PERIFANIS CONSTANTIN BAXEVANIS MARINA STAMATELOU ALICE MANIATIS 《British journal of haematology》1996,93(2):398-400
sIL-6R is a 55 kD soluble molecule mediating the interleukin-6 (IL-6) signal through the IL-6 receptor-associated transmembrane signal transducer, gp130. It has recently been suggested that sIL-6R serum levels may reflect disease severity in multiple myeloma (MM). We determined sIL-6R serum levels in 25 normal controls (NC) and in 80 MM patients at diagnosis and during the course of the disease. Measurements were done by ELISA. In NC, sIL-6R levels ranged from 14 to 40 ng/ml (median 28 ng/ml) whereas in MM patients the range was 10–200 ng/ml (median 38 ng/ml) ( P < 0.01). 61 patients entered remission and 19 were resistant. Median sIL-6R value at diagnosis was 36 ng/ml (10–120) in responding patients, and 82 ng/ml (20–200) in non-responding patients ( P < 0.001). During a follow-up from 12 to 89 months, sIL-6R values remained more or less stable in most patients. High sIL-6R levels correlated with poor survival. 相似文献
1